Regulation

Penetration Testing Secures Healthcare and Patient Data
Data and Information Penetration Testing Secures Healthcare and Patient Data

A single stolen medical record currently commands a price on the dark web that is often ten times higher than that of a credit card number, creating an unprecedented incentive for cybercriminals to target the healthcare sector. As hospitals and clinics continue to transition toward fully integrated

How Secure Is Your Data After the Cherry Health Breach?
Data and Information How Secure Is Your Data After the Cherry Health Breach?

The recent security compromise involving the sensitive digital records at Cherry Health serves as a chilling reminder that no organization is truly immune to the sophisticated tactics employed by today’s cybercriminal syndicates. When a major healthcare provider experiences an unauthorized i

Healthcare Bolsters Security Against AI Cyber Threats
Technology Healthcare Bolsters Security Against AI Cyber Threats

The rapid convergence of advanced artificial intelligence and interconnected medical infrastructure has fundamentally altered the protective requirements for sensitive patient health information and clinical operational stability. This digital transformation of patient care delivery has

Can We Trust Clinical AI Without Independent Validation?
Public Policy Can We Trust Clinical AI Without Independent Validation?

A high-stakes patient screening algorithm fails to identify a critical cardiac anomaly despite having received formal regulatory clearance months prior, leaving clinicians to grapple with the reality that marketing claims often outpace clinical reality. This scenario has become increasingly common

How Will Germany Regulate Digital Health in 2026?
Data and Information How Will Germany Regulate Digital Health in 2026?

The transformation of the German healthcare system from a legacy paper-bound hierarchy into a streamlined digital powerhouse has reached a defining milestone, fundamentally altering how eighty-three million citizens interact with medical professionals and insurance providers on a daily basis. By

How Will the First Golimumab Biosimilars Impact Treatment?
Care How Will the First Golimumab Biosimilars Impact Treatment?

The healthcare landscape shifted significantly in May 2026 when the FDA granted approval to the first biosimilar versions of golimumab, marking a new chapter for millions of patients. This regulatory milestone introduced Immgolis and Immgolis Intri as alternatives to the established reference

Loading

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later